Digital illustration of nerves and pain points in feet for neuropathy treatment.

Stem Cell Therapy with Microvascular Tissue: A Game-Changer for Peripheral Neuropathy at Cendant Stem Cell Center

/in /by

Peripheral neuropathy robs millions of comfort and mobility, causing burning pain, numbness, tingling, and weakness, often in the feet—that worsens with time. For active individuals, it can halt favorite activities like sports or martial arts. Standard treatments (Gabapentin) cannot fix the underlying issues: nerve damage combined with poor microvascular circulation that starves nerves of oxygen and nutrients.

Cendant Stem Cell Center stands out by offering an EXCLUSIVE, advanced protocol: human umbilical cord-derived mesenchymal stem cells (HUCT-MSCs) paired with FDA-regulated microvascular tissue (MVT), a specialized allograft containing real microscopic blood vessels (arterioles, capillaries, venules) and extracellular matrix. We’re one of the few U.S. clinics integrating MVT specifically for peripheral neuropathy, creating a powerful synergy that restores blood flow while regenerating nerves.

Why This Combination Excels

MVT acts as a living scaffold, rebuilding tiny vessels to improve perfusion and create an ideal healing environment. HUCT-MSCs then reduce inflammation, release neurotrophic factors (NGF, BDNF), and support nerve repair. Exosomes from the cells deliver additional regenerative signals systemically.

Evidence backs this approach:

  • The HIFLO Trial (randomized, multi-center) showed MVT dramatically improved wound healing in diabetic foot ulcers (74% closure vs. 38% standard care), with statistically significant gains in local neuropathy (118% improvement vs. 11%) and regional sensation, often within weeks.
  • Meta-analyses of MSC therapies for diabetic peripheral neuropathy confirm better nerve conduction velocity, reduced pain, and enhanced sensory function.
  • Combined vascular + cellular strategies address the “vascular-neural” double hit in neuropathy, leading to faster, more durable outcomes than stem cells alone.

This outpatient procedure uses targeted foot injections (with optional IV stem cells/exosomes for broader benefits) and requires no downtime.

Real Patient Outcome: A 60-Year-Old Martial Artist’s Quick Comeback

A patient presented to the office for treatment. He is a highly active 60-year-old dedicated to martial arts, developed debilitating peripheral neuropathy that threatened to end his training. Burning pain and numbness in his feet made kicks and stances painful and unstable.

He chose our exclusive MVT + stem cell protocol at Cendant: precise injections into the affected areas, plus a systemic IV infusion of umbilical cord stem cells and exosomes.

Results appeared remarkably fast—noticeable relief within days. Pain eased, sensation improved, and he regained confidence in movement. By follow-up, he was back to full martial arts sessions without limitations.

Surprisingly, the IV component boosted his overall health: post-treatment labs revealed unexpected improvements in kidney and liver function, highlighting the systemic regenerative power of this approach.

What Patients Experience: Rapid Onset and Sustained Gains

Early improvements often start in days to 2 weeks as circulation rebounds and inflammation drops. Optimal nerve regeneration builds over 1–3 months. Typical benefits:

  • Sharp reduction in burning/tingling pain
  • Restored foot sensation and balance
  • Renewed ability to train, walk, or enjoy hobbies
  • Bonus systemic perks like better organ function in some cases

With an outstanding safety profile (FDA-cleared MVT, minimal side effects like brief soreness), this minimally invasive option prioritizes natural healing.

If neuropathy is sidelining your active lifestyle, Cendant’s exclusive microvascular tissue-enhanced stem cell therapy offers targeted, evidence-based hope. Our team at Cendant delivers personalized, compassionate care focused on real results.